A chemist shows hydroxychloroquine tablets. On June 15, 2020, U.S. regulators are revoking emergency authorisation for the tablets. Submit.|Picture Credit:
AP.
.
.
The FDA stated that it has actually “identified that the statutory requirements for EUA are no longer fulfilled.
On June 15, the U.S. Food and Drug Administration withdrawed the emergency situation use authorization (EUA) issued for 2 drugs– hydroxychloroquine sulfate and chloroquine phosphate— for usage in certain hospitalised COVID-19 clients Prevent hydroxychloroquine in COVID-19 clients with extreme illness, says Health Ministry procedure
The FDA stated that it has “identified that the statutory criteria for EUA are no longer fulfilled.
Likewise checked out: Hydroxychloroquine does not reduce death, HEALING trial finds
In a letter to Gary L. Disbrow, Deputy Assistant Secretary Director, Medical Countermeasure Programs Biomedical Advanced Research and Advancement Authority (BARDA), FDA Chief Researcher RADM Denise M. Hinton stated “based on a review of new information and a re